A New Mouse Model to Study Acquired Lymphedema
Identifieur interne : 002691 ( Pmc/Corpus ); précédent : 002690; suivant : 002692A New Mouse Model to Study Acquired Lymphedema
Auteurs : Martin Schneider ; Annelii Ny ; Carmen Ruiz De Almodovar ; Peter CarmelietSource :
- PLoS Medicine [ 1549-1277 ] ; 2006.
Abstract
Schneider and colleagues say that the new model, published in
Url:
DOI: 10.1371/journal.pmed.0030264
PubMed: 16842020
PubMed Central: 1513046
Links to Exploration step
PMC:1513046Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A New Mouse Model to Study Acquired Lymphedema</title><author><name sortKey="Schneider, Martin" sort="Schneider, Martin" uniqKey="Schneider M" first="Martin" last="Schneider">Martin Schneider</name></author><author><name sortKey="Ny, Annelii" sort="Ny, Annelii" uniqKey="Ny A" first="Annelii" last="Ny">Annelii Ny</name></author><author><name sortKey="De Almodovar, Carmen Ruiz" sort="De Almodovar, Carmen Ruiz" uniqKey="De Almodovar C" first="Carmen Ruiz" last="De Almodovar">Carmen Ruiz De Almodovar</name></author><author><name sortKey="Carmeliet, Peter" sort="Carmeliet, Peter" uniqKey="Carmeliet P" first="Peter" last="Carmeliet">Peter Carmeliet</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">16842020</idno><idno type="pmc">1513046</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513046</idno><idno type="RBID">PMC:1513046</idno><idno type="doi">10.1371/journal.pmed.0030264</idno><date when="2006">2006</date><idno type="wicri:Area/Pmc/Corpus">002691</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002691</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A New Mouse Model to Study Acquired Lymphedema</title><author><name sortKey="Schneider, Martin" sort="Schneider, Martin" uniqKey="Schneider M" first="Martin" last="Schneider">Martin Schneider</name></author><author><name sortKey="Ny, Annelii" sort="Ny, Annelii" uniqKey="Ny A" first="Annelii" last="Ny">Annelii Ny</name></author><author><name sortKey="De Almodovar, Carmen Ruiz" sort="De Almodovar, Carmen Ruiz" uniqKey="De Almodovar C" first="Carmen Ruiz" last="De Almodovar">Carmen Ruiz De Almodovar</name></author><author><name sortKey="Carmeliet, Peter" sort="Carmeliet, Peter" uniqKey="Carmeliet P" first="Peter" last="Carmeliet">Peter Carmeliet</name></author></analytic><series><title level="j">PLoS Medicine</title><idno type="ISSN">1549-1277</idno><idno type="eISSN">1549-1676</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Schneider and colleagues say that the new model, published in
<italic>PLoS Medicine,</italic> promises to increase our understanding of lymphedema and hopefully accelerate the development and testing of new treatments.
</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Stewart, Bw" uniqKey="Stewart B">BW Stewart</name></author><author><name sortKey="Kleihues, P" uniqKey="Kleihues P">P Kleihues</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rockson, Sg" uniqKey="Rockson S">SG Rockson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Szuba, A" uniqKey="Szuba A">A Szuba</name></author><author><name sortKey="Rockson, Sg" uniqKey="Rockson S">SG Rockson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tabibiazar, R" uniqKey="Tabibiazar R">R Tabibiazar</name></author><author><name sortKey="Cheung, L" uniqKey="Cheung L">L Cheung</name></author><author><name sortKey="Han, J" uniqKey="Han J">J Han</name></author><author><name sortKey="Swanson, J" uniqKey="Swanson J">J Swanson</name></author><author><name sortKey="Beilhack, A" uniqKey="Beilhack A">A Beilhack</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Angeli, V" uniqKey="Angeli V">V Angeli</name></author><author><name sortKey="Ginhoux, F" uniqKey="Ginhoux F">F Ginhoux</name></author><author><name sortKey="Llodra, J" uniqKey="Llodra J">J Llodra</name></author><author><name sortKey="Quemeneur, L" uniqKey="Quemeneur L">L Quemeneur</name></author><author><name sortKey="Frenette, Ps" uniqKey="Frenette P">PS Frenette</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swartz, Ma" uniqKey="Swartz M">MA Swartz</name></author><author><name sortKey="Boardman, Kc" uniqKey="Boardman K">KC Boardman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mouta, C" uniqKey="Mouta C">C Mouta</name></author><author><name sortKey="Heroult, M" uniqKey="Heroult M">M Heroult</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ristimaki, A" uniqKey="Ristimaki A">A Ristimaki</name></author><author><name sortKey="Narko, K" uniqKey="Narko K">K Narko</name></author><author><name sortKey="Enholm, B" uniqKey="Enholm B">B Enholm</name></author><author><name sortKey="Joukov, V" uniqKey="Joukov V">V Joukov</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hagendoorn, J" uniqKey="Hagendoorn J">J Hagendoorn</name></author><author><name sortKey="Padera, Tp" uniqKey="Padera T">TP Padera</name></author><author><name sortKey="Kashiwagi, S" uniqKey="Kashiwagi S">S Kashiwagi</name></author><author><name sortKey="Isaka, N" uniqKey="Isaka N">N Isaka</name></author><author><name sortKey="Noda, F" uniqKey="Noda F">F Noda</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee Donaldson, L" uniqKey="Lee Donaldson L">L Lee-Donaldson</name></author><author><name sortKey="Witte, Mh" uniqKey="Witte M">MH Witte</name></author><author><name sortKey="Bernas, M" uniqKey="Bernas M">M Bernas</name></author><author><name sortKey="Witte, Cl" uniqKey="Witte C">CL Witte</name></author><author><name sortKey="Way, D" uniqKey="Way D">D Way</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Szuba, A" uniqKey="Szuba A">A Szuba</name></author><author><name sortKey="Skobe, M" uniqKey="Skobe M">M Skobe</name></author><author><name sortKey="Karkkainen, Mj" uniqKey="Karkkainen M">MJ Karkkainen</name></author><author><name sortKey="Shin, Ws" uniqKey="Shin W">WS Shin</name></author><author><name sortKey="Beynet, Dp" uniqKey="Beynet D">DP Beynet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoon, Ys" uniqKey="Yoon Y">YS Yoon</name></author><author><name sortKey="Murayama, T" uniqKey="Murayama T">T Murayama</name></author><author><name sortKey="Gravereaux, E" uniqKey="Gravereaux E">E Gravereaux</name></author><author><name sortKey="Tkebuchava, T" uniqKey="Tkebuchava T">T Tkebuchava</name></author><author><name sortKey="Silver, M" uniqKey="Silver M">M Silver</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karkkainen, Mj" uniqKey="Karkkainen M">MJ Karkkainen</name></author><author><name sortKey="Saaristo, A" uniqKey="Saaristo A">A Saaristo</name></author><author><name sortKey="Jussila, L" uniqKey="Jussila L">L Jussila</name></author><author><name sortKey="Karila, Ka" uniqKey="Karila K">KA Karila</name></author><author><name sortKey="Lawrence, Ec" uniqKey="Lawrence E">EC Lawrence</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Harvey, Nl" uniqKey="Harvey N">NL Harvey</name></author><author><name sortKey="Srinivasan, Rs" uniqKey="Srinivasan R">RS Srinivasan</name></author><author><name sortKey="Dillard, Me" uniqKey="Dillard M">ME Dillard</name></author><author><name sortKey="Johnson, Nc" uniqKey="Johnson N">NC Johnson</name></author><author><name sortKey="Witte, Mh" uniqKey="Witte M">MH Witte</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hong, Yk" uniqKey="Hong Y">YK Hong</name></author><author><name sortKey="Shin, Jw" uniqKey="Shin J">JW Shin</name></author><author><name sortKey="Detmar, M" uniqKey="Detmar M">M Detmar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tammela, T" uniqKey="Tammela T">T Tammela</name></author><author><name sortKey="Petrova, Tv" uniqKey="Petrova T">TV Petrova</name></author><author><name sortKey="Alitalo, K" uniqKey="Alitalo K">K Alitalo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ny, A" uniqKey="Ny A">A Ny</name></author><author><name sortKey="Koch, M" uniqKey="Koch M">M Koch</name></author><author><name sortKey="Schneider, M" uniqKey="Schneider M">M Schneider</name></author><author><name sortKey="Neven, E" uniqKey="Neven E">E Neven</name></author><author><name sortKey="Tong, Rt" uniqKey="Tong R">RT Tong</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="other"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">pmed</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16842020</article-id><article-id pub-id-type="pmc">1513046</article-id><article-id pub-id-type="doi">10.1371/journal.pmed.0030264</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspectives</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cancer Biology</subject><subject>Genetics/Genomics/Gene Therapy</subject><subject>Immunology</subject><subject>Pharmacology/Drug Discovery</subject><subject>Allergy/Immunology</subject><subject>Oncology</subject><subject>Surgery</subject><subject>Women's Health</subject><subject>General Medicine</subject></subj-group><subj-group subj-group-type="System Taxonomy"><subject>Cancer: breast</subject><subject>Surgery</subject><subject>Women's Health</subject><subject>Genetics</subject><subject>Immunology and allergy</subject></subj-group></article-categories><title-group><article-title>A New Mouse Model to Study Acquired Lymphedema</article-title><alt-title alt-title-type="running-head">Perspectives</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Martin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ny</surname><given-names>Annelii</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Almodovar</surname><given-names>Carmen Ruiz</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carmeliet</surname><given-names>Peter</given-names></name><xref ref-type="corresp" rid="n3">*</xref></contrib></contrib-group><author-notes><fn id="n1" fn-type="COI-statement"><p><bold>Competing Interests:</bold> The authors have declared that no competing interests exist.
</p></fn><fn id="n2" fn-type="current-aff"><p>Martin Schneider, Annelii Ny, Carmen Ruiz de Almodovar, and Peter Carmeliet are at the Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium.</p></fn><corresp id="n3">* To whom correspondence should be addressed. E-mail:
<email>peter.carmeliet@med.kuleuven.be</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2006</year></pub-date><pub-date pub-type="epub"><day>18</day><month>7</month><year>2006</year></pub-date><volume>3</volume><issue>7</issue><elocation-id>e264</elocation-id><permissions><copyright-statement>Copyright: © 2006 Schneider et al.</copyright-statement><copyright-year>2006</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><related-article id="d35e130" related-article-type="companion" ext-link-type="doi" xlink:href="10.1371/journal.pmed.0030254" xlink:title="research article" vol="3" page="e254"><article-title>Inflammatory Manifestations of Experimental Lymphatic Insufficiency</article-title></related-article><abstract abstract-type="toc"><p>Schneider and colleagues say that the new model, published in
<italic>PLoS Medicine,</italic> promises to increase our understanding of lymphedema and hopefully accelerate the development and testing of new treatments.
</p></abstract></article-meta></front><body><p>More than 1 million women worldwide develop breast cancer every year [
<xref rid="pmed-0030264-b1" ref-type="bibr">1</xref>]. For many of them, surgical removal of the breast remains the first line of treatment for this potentially deadly disease. Because breast cancer cells spread via lymph vessels, at the time that the breast is resected, locally involved lymph nodes in the armpit and part of the axillary lymphatic network are usually also removed. Consequently, normal drainage of lymph is often interrupted, causing swelling of the affected arm due to lymph accumulation—a condition termed lymphedema. Acquired lymphedema in humans may also result from irradiation, trauma, or (parasitic) infection.
</p><p>While the swelling causes discomfort and disability, an even greater health threat lies hidden in the structural and functional changes inside the chronically lymphedemic tissue. Adipocytes, keratinocytes, and fibroblasts accumulate, transforming the initially soft swollen tissue into a hard fibrotic mass with fatty degeneration and a stiff, thickened skin [
<xref rid="pmed-0030264-b2" ref-type="bibr">2–4</xref>]. In addition, there is reduced trafficking of antigen-presenting and other immune cells to the lymph nodes, and so these cells are less likely to be able to perform their immune surveillance function to defend the host against foreign antigens. As a result, the tissues affected by lymphedema are prone to persistent inflammation and infection [
<xref rid="pmed-0030264-b2" ref-type="bibr">2</xref>,
<xref rid="pmed-0030264-b4" ref-type="bibr">4</xref>]. The increased interstitial tissue pressure may collapse the veins, further aggravating the condition and in severe cases even necessitating amputation.
</p><p>Almost unimaginably, close to 400 years after the discovery of lymph vessels, there is still no cure for lymphedema, and current medical practice still relies on ancient procedures, such as manual lymph drainage via massage. A better knowledge of the molecular cues underlying the abnormalities that characterize the inflammatory tissue response to lymph stagnation is thus urgently needed to provide novel perspectives for lymphedema treatment. However, research progress in the field has been hampered by the lack of suitable experimental animal models. The new mouse model of acquired lymphatic insufficiency reported by Tabibiazar et al. in
<italic>PLoS Medicine</italic> [
<xref rid="pmed-0030264-b5" ref-type="bibr">5</xref>] may help to overcome some of these obstacles.
</p><disp-quote><p>There is still no cure for lymphedema, and current medical practice relies on ancient procedures.</p></disp-quote><sec id="s2"><title>The New Mouse Model</title><p>How did the authors develop and characterize the model? Microsurgical ablation of the lymph vessels in the tail of the mouse resulted in lymph stagnation, lymph vessel dilation (with a marked increase in tail volume), accumulation of fibroblasts, fat, and skin cells, impaired clearance of immune cells from the tail, and profound accumulation of inflammatory cells. This novel model thus closely recapitulates several hallmark features of acquired lymphedema in humans.</p><p>The model also differs from the human disease in certain aspects, however. For instance, a mouse tail lacks lymph nodes, which may play a critical role in fostering the immune response and inflammation in the edematous tissue in human lymphedema [
<xref rid="pmed-0030264-b6" ref-type="bibr">6</xref>]. It remains to be assessed whether the absence of lymph nodes influences the tissue response to lymph stasis in the mouse tail. The hydrodynamic and cellular mechanisms and the rate of lymph drainage in a horizontally positioned mouse tail also differ from those in a supine human limb, in which positional changes and muscle contractions determine lymph drainage [
<xref rid="pmed-0030264-b7" ref-type="bibr">7</xref>]. It is unclear to what extent these differences influence the disease course and severity. Moreover, it will be interesting to characterize the long-term chronic structural changes in the lymphedemic mouse tail.
</p><p>Interestingly, not only were lymph vessels dilated in the mouse tail model, but there were also 10-fold more lymphatic vessels in the lymphedemic tail than in control tails. It remains to be determined whether this increase in the number of lymphatic vessels in the lymphedemic tissue is a peculiarity of the mouse tail model, as very little information about lymphatic hyperplasia in humans with lymphedema is available. While the precise reason for this increased lymphatic vessel density remains unclear, it is conceivable that the large accumulation of inflammatory cells and the release of inflammatory cytokines may have stimulated lymphangiogenesis [
<xref rid="pmed-0030264-b8" ref-type="bibr">8</xref>,
<xref rid="pmed-0030264-b9" ref-type="bibr">9</xref>]. Another unresolved issue is to what extent inflammatory cells are merely trapped in the edematous tissue as silent bystanders or, instead, actively determine disease progression. The role of inflammation in the tissue response to lymphedema in this mouse model could be readily tested by using immunocompromised mice or knockout mice lacking specific inflammatory mediators, or by treating mice with anti-inflammatory agents.
</p></sec><sec id="s3"><title>Comparison with Previous Models</title><p>To what extent does this new model differ from existing ones? Is the new model any better?</p><p>Several models of lymphedema have been previously developed. Some were developed via surgical ablation or irradiation of the lymphatics in the rabbit ear or mouse tail [
<xref rid="pmed-0030264-b10" ref-type="bibr">10–13</xref>], others via inactivation or mutation of lymphangiogenic genes in mice, such as the
<italic>Chy</italic> mice carrying a heterozygous
<italic>Vegfr3</italic> mutation [
<xref rid="pmed-0030264-b14" ref-type="bibr">14</xref>]. These models have been generally used to study the physiological regulation of lymph flow and to assess the therapeutic potential of VEGF-C to stimulate lymphatic revascularization.
</p><p>However, apart from the
<italic>Prox1
<sup>+/−</sup></italic> mouse, which accumulates fat as a consequence of lymphatic vascular leakage [
<xref rid="pmed-0030264-b15" ref-type="bibr">15</xref>], none of these models has been used to study the chronic secondary tissue changes in response to lymphedema. Thus, unlike the previous models, Tabibiazar and colleagues' new mouse model of acquired lymphedema, in combination with powerful mouse genetics, offers exciting opportunities to dissect the molecular basis of the response to lymphedema. In addition, this new model should be valuable to evaluate the therapeutic potential of novel anti-lymphedema drugs.
</p></sec><sec id="s4"><title>Clinical Implications</title><p>One of the reasons why treatment of lymphedema is still in its infancy relates to our lack of understanding of the changes induced by lymph stagnation. Previous studies primarily focused on identifying the gene programs switched on in lymphatic endothelial cells in response to lymphangiogenic stimuli [
<xref rid="pmed-0030264-b16" ref-type="bibr">16</xref>,
<xref rid="pmed-0030264-b17" ref-type="bibr">17</xref>]. However, more cell types participate in the complex response to lymph stasis than lymphatic endothelial cells alone. For instance, chyle itself stimulates adipogenesis [
<xref rid="pmed-0030264-b15" ref-type="bibr">15</xref>], and it is conceivable that yet unidentified chemokines and growth factors in lymph affect other cell types in edematous tissues as well.
</p><p>As Tabibiazar et al. show, their new model provides opportunities to identify sets of genes previously unsuspected to be involved in acquired lymphedema. Their current analysis has already identified genes regulating inflammation, immunity, complement activation, fibrosis, oxidative stress, and angiogenesis. Obviously, the functional significance of the current gene profile will need to be further validated. Other small animal models, such as the recently generated
<italic>Xenopus laevis</italic> tadpole model of lymphangiogenesis, may accelerate the functional screening of such candidates [
<xref rid="pmed-0030264-b18" ref-type="bibr">18</xref>]. Overall, the new mouse model of acquired lymphedema promises to increase our understanding of this largely unexplained disease, and hopefully accelerate the development and testing of new treatments for this devastating disorder.
</p></sec></body><back><fn-group><fn id="n4" fn-type="financial-disclosure"><p><bold>Funding:</bold> MS is supported by the Deutsche Forchungsgemeinschaft (Germany), AN is supported by the European Union Sixth Framework Programme via a Marie Curie Intra European Fellowship, and CRA is a recipient of a fellowship from the Federation of European Biochemical Societies.
</p></fn><fn id="n5" fn-type="other"><p><bold>Citation:</bold> Schneider M, Ny A, Ruiz de Almodovar C, Carmeliet P (2006) A new mouse model to study acquired lymphedema. PLoS Med 3: e264. DOI:
<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pmed.0030264">10.1371/journal.pmed.0030264</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="pmed-0030264-b1"><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Stewart</surname><given-names>BW</given-names></name><name><surname>Kleihues</surname><given-names>P</given-names></name></person-group><source>World cancer report</source><year>2003</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><lpage>352</lpage></element-citation></ref><ref id="pmed-0030264-b2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Tammela</surname><given-names>T</given-names></name><name><surname>Petrova</surname><given-names>TV</given-names></name></person-group><article-title>Lymphangiogenesis in development and human disease</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>946</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">16355212</pub-id></element-citation></ref><ref id="pmed-0030264-b3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockson</surname><given-names>SG</given-names></name></person-group><article-title>Lymphedema</article-title><source>Curr Treat Options Cardiovasc Med</source><year>2006</year><volume>8</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">16533487</pub-id></element-citation></ref><ref id="pmed-0030264-b4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szuba</surname><given-names>A</given-names></name><name><surname>Rockson</surname><given-names>SG</given-names></name></person-group><article-title>Lymphedema: Anatomy, physiology and pathogenesis</article-title><source>Vasc Med</source><year>1997</year><volume>2</volume><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">9575606</pub-id></element-citation></ref><ref id="pmed-0030264-b5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabibiazar</surname><given-names>R</given-names></name><name><surname>Cheung</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Swanson</surname><given-names>J</given-names></name><name><surname>Beilhack</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Inflammatory manifestations of experimental lymphatic insufficiency</article-title><source>PLoS Med</source><year>2006</year><volume>3</volume><fpage>e254</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0030254</pub-id><pub-id pub-id-type="pmid">16834456</pub-id></element-citation></ref><ref id="pmed-0030264-b6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeli</surname><given-names>V</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Llodra</surname><given-names>J</given-names></name><name><surname>Quemeneur</surname><given-names>L</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name><etal></etal></person-group><article-title>B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization</article-title><source>Immunity</source><year>2006</year><volume>24</volume><fpage>203</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">16473832</pub-id></element-citation></ref><ref id="pmed-0030264-b7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swartz</surname><given-names>MA</given-names></name><name><surname>Boardman</surname><given-names>KC</given-names></name></person-group><article-title>The role of interstitial stress in lymphatic function and lymphangiogenesis</article-title><source>Ann N Y Acad Sci</source><year>2002</year><volume>979</volume><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">12543729</pub-id></element-citation></ref><ref id="pmed-0030264-b8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouta</surname><given-names>C</given-names></name><name><surname>Heroult</surname><given-names>M</given-names></name></person-group><article-title>Inflammatory triggers of lymphangiogenesis</article-title><source>Lymphat Res Biol</source><year>2003</year><volume>1</volume><fpage>201</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">15624438</pub-id></element-citation></ref><ref id="pmed-0030264-b9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristimaki</surname><given-names>A</given-names></name><name><surname>Narko</surname><given-names>K</given-names></name><name><surname>Enholm</surname><given-names>B</given-names></name><name><surname>Joukov</surname><given-names>V</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name></person-group><article-title>Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>8413</fpage><lpage>8418</lpage><pub-id pub-id-type="pmid">9525952</pub-id></element-citation></ref><ref id="pmed-0030264-b10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagendoorn</surname><given-names>J</given-names></name><name><surname>Padera</surname><given-names>TP</given-names></name><name><surname>Kashiwagi</surname><given-names>S</given-names></name><name><surname>Isaka</surname><given-names>N</given-names></name><name><surname>Noda</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics</article-title><source>Circ Res</source><year>2004</year><volume>95</volume><fpage>204</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">15192027</pub-id></element-citation></ref><ref id="pmed-0030264-b11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee-Donaldson</surname><given-names>L</given-names></name><name><surname>Witte</surname><given-names>MH</given-names></name><name><surname>Bernas</surname><given-names>M</given-names></name><name><surname>Witte</surname><given-names>CL</given-names></name><name><surname>Way</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Refinement of a rodent model of peripheral lymphedema</article-title><source>Lymphology</source><year>1999</year><volume>32</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">10494523</pub-id></element-citation></ref><ref id="pmed-0030264-b12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szuba</surname><given-names>A</given-names></name><name><surname>Skobe</surname><given-names>M</given-names></name><name><surname>Karkkainen</surname><given-names>MJ</given-names></name><name><surname>Shin</surname><given-names>WS</given-names></name><name><surname>Beynet</surname><given-names>DP</given-names></name><etal></etal></person-group><article-title>Therapeutic lymphangiogenesis with human recombinant VEGF-C</article-title><source>FASEB J</source><year>2002</year><volume>16</volume><fpage>1985</fpage><lpage>1987</lpage><pub-id pub-id-type="pmid">12397087</pub-id></element-citation></ref><ref id="pmed-0030264-b13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>YS</given-names></name><name><surname>Murayama</surname><given-names>T</given-names></name><name><surname>Gravereaux</surname><given-names>E</given-names></name><name><surname>Tkebuchava</surname><given-names>T</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema</article-title><source>J Clin Invest</source><year>2003</year><volume>111</volume><fpage>717</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">12618526</pub-id></element-citation></ref><ref id="pmed-0030264-b14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkkainen</surname><given-names>MJ</given-names></name><name><surname>Saaristo</surname><given-names>A</given-names></name><name><surname>Jussila</surname><given-names>L</given-names></name><name><surname>Karila</surname><given-names>KA</given-names></name><name><surname>Lawrence</surname><given-names>EC</given-names></name><etal></etal></person-group><article-title>A model for gene therapy of human hereditary lymphedema</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>12677</fpage><lpage>12682</lpage><pub-id pub-id-type="pmid">11592985</pub-id></element-citation></ref><ref id="pmed-0030264-b15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>NL</given-names></name><name><surname>Srinivasan</surname><given-names>RS</given-names></name><name><surname>Dillard</surname><given-names>ME</given-names></name><name><surname>Johnson</surname><given-names>NC</given-names></name><name><surname>Witte</surname><given-names>MH</given-names></name><etal></etal></person-group><article-title>Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>1072</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">16170315</pub-id></element-citation></ref><ref id="pmed-0030264-b16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>YK</given-names></name><name><surname>Shin</surname><given-names>JW</given-names></name><name><surname>Detmar</surname><given-names>M</given-names></name></person-group><article-title>Development of the lymphatic vascular system: A mystery unravels</article-title><source>Dev Dyn</source><year>2004</year><volume>231</volume><fpage>462</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">15376314</pub-id></element-citation></ref><ref id="pmed-0030264-b17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammela</surname><given-names>T</given-names></name><name><surname>Petrova</surname><given-names>TV</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name></person-group><article-title>Molecular lymphangiogenesis: New players</article-title><source>Trends Cell Biol</source><year>2005</year><volume>15</volume><fpage>434</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">16005628</pub-id></element-citation></ref><ref id="pmed-0030264-b18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ny</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Neven</surname><given-names>E</given-names></name><name><surname>Tong</surname><given-names>RT</given-names></name><etal></etal></person-group><article-title>A genetic
<italic>Xenopus laevis</italic> tadpole model to study lymphangiogenesis
</article-title><source>Nat Med</source><year>2005</year><volume>11</volume><fpage>998</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">16116431</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002691 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002691 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1513046
|texte= A New Mouse Model to Study Acquired Lymphedema
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:16842020" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |